Major depression is a debilitating brain disorder that affects one in ten adults. It is caused by an imbalance of chemicals in the brain that results in a persistent state of sadness and loss of interest in or pleasure from normal activities. Individuals with depression that have been resistant to usual treatments may give up hope for improvement. Ketamine administration is a new treatment intervention that has shown great promise for these patients.
UC Health offers intranasal ketamine as an innovative treatment that may help patients coping with treatment resistant depression. Intranasal administration does not require intravenous access and can be done in our offices. Ketamine is not FDA-approved for the treatment of depression or other psychiatric illnesses and may not be covered by your insurance provider. Visit uchealth.com/financial/ for questions regarding insurance and billing.